整形外科用生体材料市場：材料タイプ別、用途別-2025-2030年の世界予測

整形外科用生体材料市場は、2023年に163億2,000万米ドルと評価され、2024年には177億9,000万米ドルに達すると予測され、CAGR 9.39％で成長し、2030年には305億9,000万米ドルになると予測されています。

整形外科用生体材料には、損傷した骨や関節を支え、強化し、あるいは置換するために使用される、さまざまな天然物質や合成物質が含まれます。これらの材料は、筋骨格系障害の治療を進める上で不可欠であり、外科用インプラント、組織工学、再生医療において重要な役割を果たしています。整形外科用生体材料の必要性は、関節炎、骨粗鬆症、外傷などの整形外科的損傷や症状の発生率の増加から生じています。最終用途は主に病院、専門クリニック、学術研究機関です。主な成長要因としては、世界人口の高齢化、スポーツ関連傷害の増加、生体適合性、強度、人体組織との一体化を強化した新しいバイオマテリアルにつながる技術革新などが挙げられます。さらに、低侵襲手術の需要が市場拡大を後押ししており、先端セラミック、ポリマー、複合材料、生体吸収性材料が技術革新の機会をもたらしています。こうした機会を生かすため、企業は天然組織の特性を模倣し、患者の回復を高め、拒絶反応率を最小限に抑える生体材料の開発に注力すべきです。業界各社と研究機関のコラボレーションは、バイオプリンティングと個別化医療アプリケーションの進歩を促進することができます。しかし、市場開拓の課題は、高い開発コスト、厳しい規制要件、潜在的な生体適合性の問題です。さらに、この分野はコスト効率と品質のバランスを求める競合圧力に直面しており、これがイノベーションを抑制する要因となっています。技術革新と研究に最適な分野としては、整形外科インプラント用のバイオセラミックス、リアルタイムの生理学的モニタリングが可能なスマート生体材料、材料特性を向上させるナノテクノロジー・アプリケーションなどが挙げられます。これらの分野に取り組むことで、企業は進化する患者やヘルスケア提供者のニーズに沿った差別化された製品を提供することができます。このダイナミックな情勢の中でポジションを確立するためには、技術的なリーダーシップを取ろうとする大手企業や新興参入企業によって特徴づけられる、市場の競争の激しさを理解することが極めて重要です。

市場力学：急速に進化する整形外科用生体材料市場の主要市場インサイトを公開

整形外科用生体材料市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 整形外科疾患および障害の有病率の増加
  • 最近の整形外科用生体材料の動向
  • スポーツや事故による怪我の増加
• 市場抑制要因
  • 整形外科用生体材料のスケーラビリティに関する懸念
• 市場機会
  • 整形外科手術のニーズの高まり
  • ヘルスケアインフラの拡大
• 市場の課題
  • 代替品の入手可能性

ポーターの5つの力：整形外科用生体材料市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：整形外科用生体材料市場における外部からの影響の把握

外部マクロ環境要因は、整形外科用生体材料市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析整形外科用生体材料市場における競合情勢の把握

整形外科用生体材料市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス整形外科用生体材料市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、整形外科用生体材料市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨整形外科用生体材料市場における成功への道筋を描く

整形外科用生体材料市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 整形外科疾患および障害の罹患率の増加
    • 整形外科用生体材料の最近の動向
    • スポーツや事故による負傷の増加
  • 抑制要因
    • 整形外科用生体材料のスケーラビリティに関する懸念
  • 機会
    • 整形外科手術の需要増加
    • ヘルスケアインフラの拡大
  • 課題
    • 代替品の入手可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 整形外科用生体材料市場素材タイプ別

• リン酸カルシウムセメント
• セラミックスとバイオアクティブガラス
• 複合材料
• 金属
• ポリマー

第7章 整形外科用生体材料市場：用途別

• 生体吸収性組織固定
• 関節置換または再建
• オーソバイオロジクス
• 整形外科用インプラント
• 関節内補充療法

第8章 南北アメリカの整形外科用生体材料市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の整形外科用生体材料市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの整形外科用生体材料市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Arthrex, Inc.
• Biomatcan Ltd.
• CAM Bioceramics B.V.
• Collagen Matrix
• Evonik Industries AG
• Globus Medical Inc.
• Heraeus Holding
• Invibio Ltd. by Victrex PLC
• Koninklijke DSM N.V.
• Matexcel
• Medtronic PLC
• NuVasive, Inc.
• Stryker Corporation
• Victrex PLC
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. ORTHOPEDIC BIOMATERIALS MARKET RESEARCH PROCESS
• FIGURE 2. ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ORTHOPEDIC BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ORTHOPEDIC BIOMATERIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ORTHOPEDIC BIOMATERIALS MARKET DYNAMICS
• TABLE 7. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY CERAMICS & BIOACTIVE GLASSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY BIO-RESORBABLE TISSUE FIXATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT OR RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. CANADA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CHINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CHINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. INDIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ITALY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 76. ITALY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. POLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 84. POLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. QATAR ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 86. QATAR ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 106. ORTHOPEDIC BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2023

The Orthopedic Biomaterials Market was valued at USD 16.32 billion in 2023, expected to reach USD 17.79 billion in 2024, and is projected to grow at a CAGR of 9.39%, to USD 30.59 billion by 2030.

Orthopedic biomaterials encompass a range of natural and synthetic substances used to support, enhance, or replace damaged bones and joints. These materials are vital in advancing treatments for musculoskeletal disorders, playing a crucial role in surgical implants, tissue engineering, and regenerative medicine. The necessity for orthopedic biomaterials arises from the increasing incidence of orthopedic injuries and conditions such as arthritis, osteoporosis, and trauma. Their application spans across joint replacements, fracture fixation, and spinal augmentation, with end-use sectors primarily comprising hospitals, specialized clinics, and academic research institutes. Key growth factors include the aging global population, rising sports-related injuries, and technological innovations leading to new biomaterials that offer enhanced biocompatibility, strength, and integration with human tissue. Furthermore, the demand for minimally invasive procedures fuels market expansion, with advanced ceramics, polymers, composites, and bio-resorbable materials presenting opportunities for innovation. To capitalize on these opportunities, companies should focus on developing biomaterials that mimic natural tissue properties, enhance patient recovery, and minimize rejection rates. Collaborations between industry players and research institutions can drive advancements in bioprinting and personalized medicine applications. However, market growth is challenged by high development costs, stringent regulatory requirements, and potential biocompatibility issues. Additionally, the sector faces competitive pressure to balance cost-efficiency with quality, which can restrain innovation. The best areas for innovation and research include bioceramics for orthopedic implants, smart biomaterials capable of real-time physiological monitoring, and nanotechnology applications enhancing material properties. By addressing these areas, companies can deliver differentiated products that align with evolving patient and healthcare provider needs. Understanding the market's highly competitive nature, characterized by major players and emerging entrants striving for technological leadership, is crucial for positioning in this dynamic landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Orthopedic Biomaterials Market

The Orthopedic Biomaterials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of orthopedic diseases and disorders
  • Recent development in orthopedic biomaterials
  • Rising number of sports and accident-related injuries
• Market Restraints
  • Scalability concerns of orthopedic biomaterials
• Market Opportunities
  • Rising need for orthopedic surgeries
  • Expanding healthcare infrastructure
• Market Challenges
  • Availability of alternative

Porter's Five Forces: A Strategic Tool for Navigating the Orthopedic Biomaterials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Orthopedic Biomaterials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Orthopedic Biomaterials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Orthopedic Biomaterials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Orthopedic Biomaterials Market

A detailed market share analysis in the Orthopedic Biomaterials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Orthopedic Biomaterials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Orthopedic Biomaterials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Orthopedic Biomaterials Market

A strategic analysis of the Orthopedic Biomaterials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Orthopedic Biomaterials Market, highlighting leading vendors and their innovative profiles. These include Arthrex, Inc., Biomatcan Ltd., CAM Bioceramics B.V., Collagen Matrix, Evonik Industries AG, Globus Medical Inc., Heraeus Holding, Invibio Ltd. by Victrex PLC, Koninklijke DSM N.V., Matexcel, Medtronic PLC, NuVasive, Inc., Stryker Corporation, Victrex PLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Orthopedic Biomaterials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Material Type, market is studied across Calcium Phosphate Cement, Ceramics & Bioactive Glasses, Composites, Metal, and Polymers.
• Based on Application, market is studied across Bio-Resorbable Tissue Fixation, Joint Replacement or Reconstruction, Orthobiologics, Orthopedic Implants, and Viscosupplementation.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of orthopedic diseases and disorders
    • 5.1.1.2. Recent development in orthopedic biomaterials
    • 5.1.1.3. Rising number of sports and accident-related injuries
  • 5.1.2. Restraints
    • 5.1.2.1. Scalability concerns of orthopedic biomaterials
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising need for orthopedic surgeries
    • 5.1.3.2. Expanding healthcare infrastructure
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Orthopedic Biomaterials Market, by Material Type

• 6.1. Introduction
• 6.2. Calcium Phosphate Cement
• 6.3. Ceramics & Bioactive Glasses
• 6.4. Composites
• 6.5. Metal
• 6.6. Polymers

7. Orthopedic Biomaterials Market, by Application

• 7.1. Introduction
• 7.2. Bio-Resorbable Tissue Fixation
• 7.3. Joint Replacement or Reconstruction
• 7.4. Orthobiologics
• 7.5. Orthopedic Implants
• 7.6. Viscosupplementation

8. Americas Orthopedic Biomaterials Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Orthopedic Biomaterials Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Orthopedic Biomaterials Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Arthrex, Inc.
• 2. Biomatcan Ltd.
• 3. CAM Bioceramics B.V.
• 4. Collagen Matrix
• 5. Evonik Industries AG
• 6. Globus Medical Inc.
• 7. Heraeus Holding
• 8. Invibio Ltd. by Victrex PLC
• 9. Koninklijke DSM N.V.
• 10. Matexcel
• 11. Medtronic PLC
• 12. NuVasive, Inc.
• 13. Stryker Corporation
• 14. Victrex PLC
• 15. Zimmer Biomet Holdings, Inc.